Source: Startupticker

Nagi Bioscience: Nagi Bioscience brings SydLab platform to five leading academic labs

Nagi Bioscience, focussing on laboratory technologies for alternative model organisms research, launched its Priority Access Program. With a focus on research applications in oncology, neurodegenerative diseases, aging and age-related conditions, and toxicology, SydLab One is set to facilitate and accelerate the ground-breaking research projects of the five participating laboratories.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Matteo Cornaglia's photo - Co-Founder & CEO of Nagi Bioscience

Co-Founder & CEO

Matteo Cornaglia

CEO Approval Rating

100/100

Read more